| Adriana Neagoe, MD | |
|
945 Concord St, Framingham, MA 01701-4613 | |
| (508) 283-7898 | |
| (508) 764-2462 |
| Full Name | Adriana Neagoe |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 945 Concord St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124049002 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 156793 (Massachusetts) | Primary |
| Entity Name | The Commonwealth Of Massachusetts |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326155458 PECOS PAC ID: 8820906860 Enrollment ID: O20050203000148 |
News Archive
Kaiser Health News senior correspondent Mary Agnes Carey reports that, by a vote of 219-210, the House of Representatives has cleared the Senate-passed health care bill for President Barack Obama's signature. The House will now vote on a separate package of legislative changes to that bill - known as a reconciliation package - to send it to the Senate for debate this week.
Sofie Biosciences, Inc., offering a comprehensive range of products from pre-clinical PET imaging systems to new PET molecular imaging probes to better understand human disease, has been told that a U.S. Patent (8,101,740) will be granted by the United States Patent Office on technology that has been exclusively licensed to Sofie. The patent covers a family of novel PET probes, known as [18F]FAC.
Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".
In a month that has seen Queensland Health appear to lurch from crisis to crisis a public hospital in north Queensland which services a large area has been left without a working cardiac surgeon.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adriana Neagoe, MD 34 A Street, Framingham, MA 01701 Ph: (508) 283-7898 | Adriana Neagoe, MD 945 Concord St, Framingham, MA 01701-4613 Ph: (508) 283-7898 |
News Archive
Kaiser Health News senior correspondent Mary Agnes Carey reports that, by a vote of 219-210, the House of Representatives has cleared the Senate-passed health care bill for President Barack Obama's signature. The House will now vote on a separate package of legislative changes to that bill - known as a reconciliation package - to send it to the Senate for debate this week.
Sofie Biosciences, Inc., offering a comprehensive range of products from pre-clinical PET imaging systems to new PET molecular imaging probes to better understand human disease, has been told that a U.S. Patent (8,101,740) will be granted by the United States Patent Office on technology that has been exclusively licensed to Sofie. The patent covers a family of novel PET probes, known as [18F]FAC.
Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Vocera Communications, Inc., the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that its founder and chief technology officer, Robert Shostak, PhD, has been awarded the 2013 Jean-Claude Laprie Award in Dependable Computing for his co-authored paper, "The Byzantine Generals Problem".
In a month that has seen Queensland Health appear to lurch from crisis to crisis a public hospital in north Queensland which services a large area has been left without a working cardiac surgeon.
› Verified 6 days ago
Joseph G. D'alton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 463 Worcester Rd, Suite 101, Framingham, MA 01701 Phone: 508-820-0469 Fax: 508-626-1985 | |
Ashley Lee Shepard, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Worcester Rd Ste 201, Framingham, MA 01702 Phone: 508-845-1110 | |
Dr. Sean Orin Mackintosh, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Frederick Abbott Way, Framingham, MA 01701 Phone: 508-879-9800 Fax: 508-875-1348 | |
Dr. James Allen Kennedy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 88 Lincoln St, Framingham, MA 01702 Phone: 508-879-9800 | |
Robert Merle Johnston, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 354 Waverly St, Advocates Inc., Framingham, MA 01702 Phone: 508-661-2020 | |
Dr. Jacob Goldberg, D.O. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 359 Union Ave, Framingham, MA 01702 Phone: 508-620-1919 Fax: 508-820-3093 |